Cocaine Addiction

What cocaine is and how it affects the brain

Cocaine is a sympathomimetic stimulant derived from the coca plant that works by blocking the reuptake of dopamine, norepinephrine, and serotonin in the brain's synapses. By preventing these neurotransmitters from being cleared, cocaine causes a rapid accumulation of dopamine in the reward pathways, producing an intense but brief euphoria. The high from powder cocaine, typically snorted, lasts approximately thirty to sixty minutes. Crack cocaine, the freebase form that is smoked, reaches the brain faster and produces a more intense high that lasts only five to fifteen minutes.

The brevity of the high is central to why cocaine produces such powerful addiction. The sharp drop in dopamine after the high creates an unpleasant crash, and the natural response is to use again to restore the feeling. This binge pattern, in which the person uses repeatedly to avoid the crash, accelerates tolerance and rapidly rewires the brain's reward circuitry. Over time the brain reduces its own baseline dopamine production and sensitivity, so ordinary activities and pleasures feel flat and the drug becomes the only reliable source of reward.

Cocaine use disorder is recognized as a legitimate, treatable substance use disorder by the DSM-5, NIDA, and SAMHSA. The diagnosis requires meeting at least two of eleven clinical criteria over twelve months. The absence of FDA-approved medications for cocaine use disorder makes behavioral therapy the foundation of treatment, and The Archangel Centers specializes in the behavioral approaches with the strongest evidence.

The contaminated supply: fentanyl in cocaine

An increasingly important safety issue is fentanyl contamination in the illicit cocaine supply. DEA and public health surveillance in both New Jersey and North Carolina have documented fentanyl in cocaine samples, sometimes without any other opioid being present. This means that someone who uses cocaine and has no opioid tolerance can receive a potentially lethal fentanyl dose without knowing it.

From a harm reduction perspective, this means that naloxone is relevant for anyone who uses cocaine, not just people who use opioids. It also means that fentanyl test strips, which can detect fentanyl contamination before use, are a harm reduction tool relevant to cocaine users. The Archangel Centers includes education about contaminated supply risks and naloxone access in our cocaine treatment programming.

Health risks of cocaine use

Cocaine strains the cardiovascular system in ways that can be dangerous even in young, otherwise healthy people. Its simultaneous effects on the sympathetic nervous system, including elevated heart rate, blood pressure, and coronary vasoconstriction, create conditions for cardiac events that account for a disproportionate share of cocaine-related emergency department visits.

• Cardiovascular: hypertension, tachycardia, coronary artery spasm, myocardial infarction (heart attack), arrhythmias, cardiomyopathy, aortic dissection, sudden cardiac death
• Neurological: ischemic and hemorrhagic stroke, seizures, movement disorders, cognitive impairment with chronic use
• Psychiatric: cocaine-induced psychosis, severe depression during the crash phase, suicidality, worsening anxiety and mood disorders
• Nasal and sinus: septal perforation, chronic sinusitis, anosmia from intranasal use
• Pulmonary: crack lung (acute respiratory syndrome), pulmonary hypertension, hemoptysis from smoking
• Infectious: HIV and hepatitis C transmission risk associated with injection use and risky behavior
• Pregnancy: placental abruption, preterm labor, fetal growth restriction, neonatal withdrawal
• Mixing cocaine with alcohol produces cocaethylene in the liver, a compound that is more cardiotoxic than either drug alone

Cocaine withdrawal: the crash and recovery curve

Unlike alcohol or benzodiazepines, cocaine withdrawal does not carry a seizure risk and is rarely medically dangerous. However, it is psychologically brutal and is one of the strongest drivers of relapse. The psychological intensity of the crash is often underestimated by people who have not experienced it, and minimizing it leads to inadequate support during this vulnerable period.

Cocaine withdrawal follows a three-phase pattern. The crash begins within hours to a day after a binge ends and lasts one to four days, characterized by extreme fatigue, intense dysphoria, increased sleep, hyperphagia, and a temporary drop in cravings as the body crashes. The withdrawal phase follows over the next several days to about two weeks and is marked by low mood, anhedonia (inability to experience pleasure), fatigue, persistent cravings, irritability, and vivid, sometimes disturbing dreams. The extinction phase can last weeks to months and features intermittent cravings triggered by environmental and emotional cues associated with past use, a pattern driven by conditioned learning in the brain's reward circuitry.

Depression during the crash can be severe and, in some cases, reaches the threshold of suicidal ideation. This is why clinical monitoring during early abstinence is important and why outpatient programming with regular check-ins provides meaningful protection. This page is educational and is not medical advice.

• Crash phase (hours to 1-4 days): extreme fatigue, dysphoria, increased sleep, reduced cravings temporarily
• Withdrawal phase (days 2-10): low mood, anhedonia, fatigue, strong cravings, irritability, vivid dreams
• Extinction phase (weeks to months): intermittent cravings triggered by people, places, and emotional states
• Depression and suicidal ideation possible during the crash, requiring clinical monitoring

Treatment for cocaine use disorder: behavioral therapies

There is no FDA-approved medication specifically for cocaine use disorder, which is why evidence-based behavioral therapy is the foundation of effective treatment. The Archangel Centers uses the therapies with the strongest research support in an outpatient PHP, IOP, and standard outpatient framework. We do not provide medical detox, inpatient, or residential rehab. When cocaine is used alongside substances that require medically supervised withdrawal, we coordinate that placement with licensed partners.

Contingency management (CM) is one of the most robustly evidence-based interventions for stimulant use disorder. It uses positive reinforcement, typically tangible rewards for verified drug-free urine tests, to build new behavioral patterns. Research across multiple clinical trials shows CM produces higher rates of sustained abstinence and better treatment retention than other approaches alone. Cognitive Behavioral Therapy (CBT) helps clients identify the triggers, thought patterns, and behavioral chains that lead to cocaine use and build concrete relapse prevention skills.

The Community Reinforcement Approach (CRA) is a comprehensive behavioral program that reshapes the client's environment to make sobriety more rewarding than cocaine use. Motivational Interviewing resolves ambivalence and strengthens internal motivation for change. The Matrix Model is an intensive outpatient approach developed specifically for stimulant users that combines individual therapy, group education, family involvement, drug testing, and twelve-step participation in a structured format with a strong evidence base.

• Contingency management: positive reinforcement of verified abstinence, one of the strongest evidence-based interventions for stimulant use disorder
• Cognitive Behavioral Therapy (CBT): trigger identification, thought restructuring, relapse prevention skill building
• The Matrix Model: structured intensive outpatient program designed specifically for stimulant users
• Community Reinforcement Approach: reshapes life to make sobriety more rewarding than use
• Motivational Interviewing: resolves ambivalence, strengthens internal motivation
• Group therapy and twelve-step facilitation where appropriate
• PHP, IOP, and standard outpatient continuing care with regular clinical reassessment

Treating co-occurring conditions

Depression, anxiety, ADHD, bipolar disorder, and PTSD frequently co-occur with cocaine use disorder. In many cases, cocaine use began as self-medication for one of these conditions, and the stimulant effect temporarily relieved symptoms of depression or ADHD before tolerance and the crash deepened both problems. Treating the cocaine use disorder without addressing these underlying conditions leaves a gap that strongly predicts relapse.

At The Archangel Centers, psychiatric evaluation and dual diagnosis treatment are standard. A psychiatric provider can evaluate whether non-addictive medications for depression, anxiety, ADHD, or other conditions are appropriate. Treating ADHD with appropriate non-stimulant or carefully supervised stimulant medication can remove the self-medication driver of cocaine use for clients in whom this is a primary mechanism.

Can I keep working while in cocaine treatment?

Yes, for most people. The flexibility of outpatient programming is one of its key clinical advantages. Intensive Outpatient programs at The Archangel Centers in New Jersey and North Carolina typically meet three to four mornings or evenings per week, which fits around most work schedules. Standard outpatient is lighter still. PHP requires a fuller daily commitment initially but steps down as clients stabilize.

Many clients in our programs maintain employment throughout treatment, which has its own clinical benefits: work provides structure, purpose, and financial stability that support recovery. FMLA protection is available for eligible employees who need protected leave for treatment.